Spend $99, get free U.S. shipping*

Tariff now required on U.S. shipments. Learn more »

Tel: 1-866-456-3768 Fax: 1-866-544-8993

Due to the current situation in Israel some orders may be delayed

How does Aromasin compare to tamoxifen or letrozole for breast cancer treatment?

Aromasin, tamoxifen, and letrozole are all used in hormone-sensitive breast cancer, but they work differently and are used at different stages. Aromasin may be used after tamoxifen or as an alternative to other aromatase inhibitors like letrozole, depending on a patient’s specific needs.

Understanding Your Options

Women with hormone receptor-positive breast cancer are often offered several medication choices. If you’re comparing Aromasin, tamoxifen, and letrozole, it’s likely you’re managing early-stage or advanced breast cancer after surgery or menopause. Here’s what to know:

  • Aromasin and letrozole are aromatase inhibitors used after menopause.
  • Tamoxifen is a selective estrogen receptor modulator (SERM), often used before menopause.
  • Each drug has different side effect profiles, treatment phases, and hormone interaction mechanisms.

 

This helps explain why doctors tailor hormone therapy choice to your age, menopause status, and prior treatment response.

 

How They Work and When They’re Used

How it works

Aromasin works by irreversibly inhibiting the aromatase enzyme, which reduces estrogen production in postmenopausal women. This may slow the growth of hormone-sensitive tumors that depend on estrogen. Tamoxifen blocks estrogen receptors, preventing estrogen from acting on breast tissue, while letrozole also lowers estrogen production by reversibly inhibiting aromatase.

Clinical applications

Aromasin is used after 2–3 years of tamoxifen to complete a 5-year hormonal therapy in postmenopausal women. Letrozole may be used as an initial or extended therapy. Tamoxifen is typically the first-line hormone therapy for premenopausal women or those not suitable for aromatase inhibitors.

 

Safety and Effectiveness

Safety profile

The official prescription information lists common Aromasin side effects such as hot flashes, joint pain, and fatigue. Aromasin may also cause bone thinning over time. Letrozole has a similar profile, while tamoxifen may increase the risk of blood clots and uterine cancer in some patients.

FDA approval and indications

All three medications, Aromasin, tamoxifen, and letrozole, are FDA-approved for specific stages in the treatment of hormone-receptor-positive breast cancer. Aromasin is indicated for use in postmenopausal women with early or advanced breast cancer, especially after tamoxifen treatment.

 

Where to Access Aromasin

How to obtain safely

A licensed online pharmacy like IsraelPharm offers international access to Aromasin with proper prescription documentation. It’s essential to consult your oncologist before starting or switching hormone therapies.

 

Key Takeaways

  • Aromasin may be used in postmenopausal women after tamoxifen or instead of other aromatase inhibitors.
  • It works by blocking estrogen production, similar to letrozole, but via a different mechanism.
  • Tamoxifen blocks estrogen receptors and is more common in premenopausal women.
  • Each drug has unique side effect profiles requiring individualized risk–benefit discussions.
  • You can access Aromasin internationally through a licensed pharmacy like IsraelPharm.

 

FAQ

Can I switch from tamoxifen to Aromasin?

Yes, switching is sometimes recommended after 2–3 years of tamoxifen to complete 5 years of hormonal therapy, especially in postmenopausal women. Discuss this plan with your oncologist.

Which is more effective: Aromasin or letrozole?

Both are aromatase inhibitors with similar effectiveness, but individual patient response and risk profiles may influence which is preferred. Your doctor will consider these factors.

What are the benefits of using Aromasin over tamoxifen?

Aromasin may reduce the risk of cancer recurrence in postmenopausal women who’ve already taken tamoxifen. However, it may carry a higher risk of joint pain or bone loss.

Is Aromasin suitable for premenopausal women?

No, Aromasin is generally intended for postmenopausal women. Tamoxifen is typically used for premenopausal hormone-receptor-positive breast cancer.

How much does Aromasin cost from IsraelPharm?

Prices vary depending on supply and location. IsraelPharm offers access to Aromasin at competitive international rates—contact their pharmacy team for current pricing.

 

Login

Fast Delivery
Ships from Israel
Secure Payment
Genuine Brands
Pharmacist Oversight
Proudly Israeli
Free Shipping on orders over $99*

Having issues?

Daily from 9am-8pm EST.
IsraelPharm c/o SUBS Ltd. Ha'Uman 5 Bet Shemesh Israel, 9906105

Sign up for $10 off your first order!

Enjoy exclusive deals we only share via email

Sign up for $10 off your first order!

Enjoy exclusive deals we only share via email